Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 24.31 --0 (-0%)
Previous Close $24.31    52 Week High
Open $24.31    52 Week Low
Day High $24.31    P/E N/A 
Day Low $24.31    EPS
Volume 73